JP2000354623A - Deodorant and deodorizing spray - Google Patents
Deodorant and deodorizing sprayInfo
- Publication number
- JP2000354623A JP2000354623A JP11167462A JP16746299A JP2000354623A JP 2000354623 A JP2000354623 A JP 2000354623A JP 11167462 A JP11167462 A JP 11167462A JP 16746299 A JP16746299 A JP 16746299A JP 2000354623 A JP2000354623 A JP 2000354623A
- Authority
- JP
- Japan
- Prior art keywords
- deodorant
- flavonoid
- green tea
- odor
- dirt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
【０００１】[0001]
【発明の属する技術分野】本発明は、汚物等から発せら
れる悪臭、異臭を持続的に消臭することができる持続性
消臭剤及びこの消臭剤を噴出することがができる消臭ス
プレーに関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a persistent deodorant capable of continuously eliminating malodors and unpleasant odors emitted from filth and the like, and to a deodorant spray capable of ejecting the deodorant. .
【０００２】[0002]
【従来の技術】従来から、汚物等から発せられる悪臭、
異臭を消臭することができる消臭剤が種々開発され、普
及している。例えば、幼児や寝たきり介護者などのいる
家庭、福祉施設、病院などにおいて、オマルを使用して
排便を行なうような場合では、汚物を便器に捨てるまで
の間に、部屋中に汚物の臭気が飛散して、臭気が立ち込
めてしまうことがあるので、種々の消臭剤が使用されて
いる。2. Description of the Related Art Conventionally, odors generated from filth, etc.
Various deodorants capable of deodorizing off-flavors have been developed and are widely used. For example, in homes, welfare facilities, hospitals, etc. where infants and bedridden caregivers are used, when stool is used for defecation, the odor of filth scatters in the room before the sewage is dumped in the toilet. Therefore, various odors are used because odors may be trapped.
【０００３】[0003]
【発明が解決しようとする課題】しかしながら、従来の
消臭剤では、持続的な消臭効果が少ないことや臭気源を
被覆して臭気を封じ込めてしまうような作用が無いこと
から、その用途は、瞬間的な消臭や既に飛散してしまっ
ている臭気を対象とした消臭に限られていた。However, since the conventional deodorant has little continuous deodorizing effect and does not have the effect of covering the odor source and containing the odor, the use of the conventional deodorant is limited. However, it was limited to instantaneous deodorization and deodorization for odors that had already scattered.
【０００４】そこで、本発明は、持続的な消臭効果を有
するとともに、汚物からの臭気の飛散を有効に防止でき
る消臭剤およびこの消臭剤を収容した消臭スプレーを提
供することにある。Accordingly, an object of the present invention is to provide a deodorant having a continuous deodorizing effect and capable of effectively preventing odors from being scattered from wastes, and a deodorant spray containing the deodorant. .
【０００５】[0005]
【課題を解決するための手段】上記目的を達成するため
に、請求項１記載の消臭剤では、フラボノイドを含有す
るとともに、ムース性状を備えた消臭剤を採用する。こ
の手段では、フラボノイドが持続的な消臭作用を発揮す
るとともに、ムース性状を備えているため、臭気源であ
る汚物等を被覆（マスキング）するとともに、消臭成分
を飛散させないようにすることができるので、異臭や悪
臭の飛散を持続的に防止できる。Means for Solving the Problems In order to achieve the above object, the deodorant according to claim 1 employs a deodorant containing flavonoids and having mousse properties. In this means, the flavonoid exerts a continuous deodorizing effect and has a mousse property, so that it is possible to cover (mask) dirt and the like as an odor source and not to disperse deodorant components. As a result, scattering of off-flavors and odors can be continuously prevented.
【０００６】請求項２記載の消臭剤では、消臭剤に含有
するフラボノイドを、緑茶から抽出した緑茶フラボノイ
ドを使用する。フラボノイドは、植物に広く含まれてお
り、中でも緑茶には多く含まれていることが実証されて
いる。中でも、緑茶フラボノイドは、抽出を確実にで
き、高い消臭効果を発揮するので、好適である。尚、
「フラボノイド」とは、二つのフェニル基がピラン環あ
るいはそれに近い構造の三つの炭素原子を介して結合し
ている物質群の総称であり、フラボン、イソフラボン、
フラボノール、フラバノン、フラバノール、カテキン、
オーロン、アントシアニン、カルコン、ジヒドロカルコ
ン等を含む化合物群を意味する。また、「緑茶フラボノ
イド」には、ケンフェロール、クエルセチン、ミリセチ
ン等が含まれていることが、鈴江らによって報告されて
いる（食品工業、Ｖｏｌ．２６．Ｎｏ．１６．１９８
３）。[0006] In the deodorant according to the second aspect, a green tea flavonoid extracted from green tea is used as the flavonoid contained in the deodorant. Flavonoids are widely found in plants, and among them, green tea has been demonstrated to be found in large amounts. Among them, green tea flavonoids are preferable because they can reliably extract and exhibit a high deodorizing effect. still,
"Flavonoid" is a general term for a group of substances in which two phenyl groups are bonded via three carbon atoms in a pyran ring or a structure similar thereto, and includes flavone, isoflavone,
Flavonol, flavanone, flavanol, catechin,
A group of compounds including auron, anthocyanins, chalcone, dihydrochalcone, and the like. It has been reported by Suzue et al. That "green tea flavonoids" include kaempferol, quercetin, myricetin, and the like (Food Industry, Vol. 26, No. 16.198).
3).
【０００７】請求項３記載の消臭剤では、消臭成分とし
て、緑茶フラボノイドと葉緑素を併用する。この手段で
は、即効性の消臭効果を発揮する緑茶フラボノイドと遅
効性の消臭効果を発揮する葉緑素を併用することで、よ
り持続性のある消臭剤を提供することができる。[0007] In the deodorant of the third aspect, green tea flavonoids and chlorophyll are used in combination as deodorant components. In this means, a more persistent deodorant can be provided by using a green tea flavonoid exhibiting an immediate deodorizing effect and a chlorophyll exhibiting a delayed deodorizing effect.
【０００８】請求項４では、請求項１〜３のいずれかに
記載の消臭剤を噴出（噴霧）する消臭スプレーを採用
し、汚物等に消臭剤を噴霧する作業の簡易化、容易化を
図る。According to a fourth aspect of the present invention, the deodorant spray for ejecting (spraying) the deodorant according to any one of the first to third aspects is employed, so that the operation of spraying the deodorant on filth or the like can be simplified and facilitated. Plan.
【０００９】[0009]
【発明の実施の形態】以下に、本発明に係る消臭剤の実
施の形態を、実施例および実験例によって説明する。実
施例では、消臭剤をスプレーノズルが設けられたスプレ
ー容器（図示せず。）に収容する。尚、容量は、適宜選
択できるが、一本あたり２９０ｍｌ程度が使い勝手や価
格の面で好ましい。スプレーノズルや容器形状は、特に
限定するものではなく、適宜選択可能である。DESCRIPTION OF THE PREFERRED EMBODIMENTS Embodiments of the deodorant according to the present invention will be described below with reference to examples and experimental examples. In the embodiment, the deodorant is accommodated in a spray container (not shown) provided with a spray nozzle. In addition, the capacity can be appropriately selected, but about 290 ml per one is preferable in terms of usability and price. The spray nozzle and the shape of the container are not particularly limited, and can be appropriately selected.
【００１０】次に、消臭剤の配合は、ムース性状を形成
するための脂肪酸アミン誘導体からなる発泡剤と界面活
性剤から構成される一般的な消臭剤の基本配合に、フラ
ボノイドを含有させればよい。尚、基本配合は、ムース
性状が形成できるものであれば、適宜選択可能である。Next, the deodorant is formulated by adding a flavonoid to the basic blend of a general deodorant comprising a foaming agent comprising a fatty acid amine derivative for forming mousse properties and a surfactant. Just do it. The basic composition can be appropriately selected as long as it can form mousse properties.
【００１１】ここで、フラボノイドの含有量は、消臭効
果をより有効に、かつ持続的に発揮させるために、２．
０％以上（重量パーセント）とすることが望ましい。Here, the content of the flavonoid is set at 2. to make the deodorizing effect more effective and sustained.
Desirably, it is 0% or more (weight percent).
【００１２】実施例である消臭剤の使用方法について説
明すると、トイレで使用する場合は、消臭剤が収容され
たスプレー容器を良く振って、頭部のノズル部分を下側
に向けて汚物に向けて噴霧する。噴霧量は、様式トイレ
では、トイレの便鉢の貯水槽が隠れる程度が好ましい。The method of using the deodorant according to the embodiment will be described. When used in a toilet, the spray container containing the deodorant is shaken well, and the nozzle portion of the head is directed downward to contaminate the waste. Spray toward. In the case of a style toilet, the spray amount is preferably such that the water tank of the toilet bowl of the toilet is hidden.
【００１３】本発明に係る消臭剤の消臭効果についての
実験を行なったので、以下に説明する。まず、悪臭原体
としては、アンモニア水を使用した。臭気測定は、臭気
測定器による測定と官能試験を併用して行なった。尚、
臭気測定器は、キーエンス社製の半導体香りセンサＮＳ
シリーズを使用した。An experiment was conducted on the deodorizing effect of the deodorant according to the present invention, which will be described below. First, ammonia water was used as the odor substance. The odor measurement was performed by using both the measurement with an odor measuring device and the sensory test. still,
The odor measuring device is a semiconductor fragrance sensor NS manufactured by KEYENCE.
Used series.
【００１４】官能試験を併用したのは、臭いセンサーに
よる臭気の定量化は、測定する臭気により臭いセンサー
値に差が生じるためである。臭気の測定時間は、２分間
である。The reason why the sensory test is used together is that the odor quantification by the odor sensor causes a difference in the odor sensor value depending on the odor to be measured. The odor measurement time is 2 minutes.
【００１５】図１に基づいて、試験方法及び試験結果を
具体的に述べると、まず、１．５Ｌのプラスチック容器
１中の臭気を基準（コントロール）とする（即ち、臭い
センサー値を１００にする）。Referring to FIG. 1, the test method and test results will be specifically described. First, the odor in the 1.5 L plastic container 1 is set as a reference (control) (ie, the odor sensor value is set to 100). ).
【００１６】次に、１７０ｃｃのプラスチックカップ２
にアンモニア水３を０．２ｇ入れ、このアンモニア水３
から発せられるアンモニア臭の臭気を臭気測定器４によ
り測定するとともに、室温２０度の条件で、男女各５名
・計１０名による官能検査で評価を行なった。Next, a 170 cc plastic cup 2
0.2 g of ammonia water 3
The odor of ammonia odor emitted from the odor was measured by the odor measuring device 4, and the evaluation was carried out by a sensory test by a total of 10 persons, each of 5 men and women, at room temperature of 20 ° C.
【００１７】このときの臭気測定器４の臭いセンサ値は
４１２であって、官能評価は、非常に強いアンモニア臭
が得られるという結果であった。尚、臭気測定器４の最
大のセンサ値は９９９である。At this time, the odor sensor value of the odor measuring device 4 was 412, and the sensory evaluation was such that a very strong ammonia odor was obtained. Note that the maximum sensor value of the odor measuring device 4 is 999.
【００１８】続いて、図１に示すように、新たに１７０
ｃｃのプラスチックカップ２にアンモニア水３を０．２
ｇ入れ、そのアンモニア水３の上に消臭剤５をムース状
に噴霧（スプレー）して、上方から見たときにプラスチ
ックカップ２の底が見えなくなるようにマスキングし
た。Subsequently, as shown in FIG.
Add ammonia water 3 to cc plastic cup 2
g, and the deodorant 5 was sprayed (sprayed) on the ammonia water 3 in a mousse shape so that the bottom of the plastic cup 2 was masked when viewed from above.
【００１９】このときの臭気測定器４の臭いセンサ値は
１７９であって、官能評価は、僅かにアンモニア臭が得
られるという程度の結果であって、消臭剤５でマスキン
グしなかった場合のサンサ値４１２を大きく下回った。
この結果から本消臭剤５による消臭効果が優れているこ
とがわかる。At this time, the odor sensor value of the odor measuring device 4 was 179, and the sensory evaluation was such that a slight ammonia odor was obtained. It was significantly below the Sanza value of 412.
From this result, it can be seen that the deodorant 5 has an excellent deodorizing effect.
【００２０】上記実験結果を、以下の表１に示すので、
参照にされたい。The results of the above experiments are shown in Table 1 below.
Please refer to.
【表１】 また、本願発明者が確認したところによると、本発明に
係る消臭剤は、約１０時間程度にわたり、安定した消臭
効果を発揮することもわかり、市販の消臭剤と比較して
消臭効果の持続性が高いことがわかった。[Table 1] In addition, the inventors of the present invention confirmed that the deodorant according to the present invention exerts a stable deodorant effect for about 10 hours, and has a deodorant effect as compared with a commercially available deodorant. The effect was found to be highly persistent.
【００２１】尚、緑茶から未変性９５％エタノールで抽
出した抽出物には、多くの成分が混合抽出されている
が、一般に、葉緑素部、精油部、フラボノイド部、残さ
部に大きく区分できる。The extract extracted from green tea with undenatured 95% ethanol contains many components mixed and extracted. In general, the extract can be roughly classified into a chlorophyll part, an essential oil part, a flavonoid part, and a residue part.
【００２２】この４区分のうち、葉緑素部、フラボノイ
ド部に消臭効果が一般的に認められており、緑茶フラボ
ノイドの消臭作用は、フラボノイドのフェノール基と−
ＮＨ基との結合等に起因すると考えられている。Of these four categories, deodorizing effects are generally recognized in the chlorophyll portion and flavonoid portion, and the deodorizing effect of green tea flavonoids is due to the phenol group of flavonoids
It is thought to be caused by bonding to an NH group or the like.
【００２３】緑茶フラボノイドは、即効的な消臭効果を
有するが、ムース性状とすることによって、汚物等を被
覆するとともに、消臭剤を発散させないようにできるの
で、持続的な消臭効果を効果的に発揮させることができ
る。Green tea flavonoids have an immediate deodorizing effect. However, since they have a mousse property, they can coat dirt and the like, and can prevent the deodorant from diffusing. Can be effectively demonstrated.
【００２４】また、葉緑素は、持続的、遅効的な消臭作
用を発揮することが知られているので（鈴江等、食品工
業、Ｖｏｌ．２６．Ｎｏ．１６．１９８３）、緑茶フラ
ボノイドと葉緑素を併用してもよく、併用すれば、消臭
効果の持続性が、更に高めることができる。Also, since chlorophyll is known to exhibit a persistent and slow deodorizing action (Suzue et al., Food Industry, Vol. 26, No. 16.1983), green tea flavonoids and chlorophyll are used. They may be used in combination, and if used in combination, the persistence of the deodorizing effect can be further enhanced.
【００２５】以上説明した、本発明に係る消臭剤および
消臭スプレーは、悪臭や異臭を発するお汚物等に広く適
用されるものである。The deodorant and deodorant spray according to the present invention described above are widely applied to foul odors and other odors and the like.
【００２６】[0026]
【発明の効果】本発明に係る消臭剤によれば、汚物から
発散する臭気を消臭するとともに、汚物を被覆（マスキ
ング）できるので、持続性の高い消臭効果が得られる。
消臭スプレーの形態で使用すれば、消臭剤を、汚物等に
離れたところから簡易に噴霧できるので、大変便利であ
る。According to the deodorant of the present invention, since the odor emitted from the filth can be deodorized and the filth can be covered (masked), a highly persistent deodorizing effect can be obtained.
When used in the form of a deodorant spray, the deodorant can be easily sprayed onto filth or the like from a distance, which is very convenient.
【００２７】また、緑茶フラボノイドは、天然消臭剤で
あることから、人体等に害を及ぼす心配がないので、安
心して使用でき、安全である。更に、緑茶フラボノイド
と葉緑素を併用すれば、持続性の更に高い消臭剤が得る
ことができるので、更に便利であり、使用範囲を更に広
げることができる。Since green tea flavonoids are natural deodorants, they do not have to worry about harm to the human body and the like, so they can be used safely and are safe. Furthermore, if green tea flavonoids and chlorophyll are used in combination, a more persistent deodorant can be obtained, which is more convenient and can further widen the range of use.
【００２８】本発明に係る消臭剤および消臭スプレー
は、幼児や寝たきり介護者などのいる家庭、福祉施設、
病院など、更には、ペットを飼う家庭やペットホテルな
どにおいて、広く使用され得るのものなので、便利であ
る。The deodorant and the deodorant spray according to the present invention can be used in homes, welfare facilities, etc. where infants and bedridden caregivers are present.
It is convenient because it can be widely used in hospitals, pet homes, pet hotels, and the like.
【図１】本発明に係る消臭剤の効果を検証するための実
験方法を簡易に示す図である。FIG. 1 is a diagram simply showing an experimental method for verifying the effect of a deodorant according to the present invention.
５ 消臭剤 5 Deodorant
Claims (4)
ス性状を備えたことを特徴とする消臭剤。1. A deodorant comprising a flavonoid and having mousse properties.
た緑茶フラボノイドであることを特徴とする請求項１記
載の消臭剤。2. The deodorant according to claim 1, wherein the flavonoid is a green tea flavonoid extracted from green tea.
たたことを特徴とする請求項２記載の消臭剤。3. The deodorant according to claim 2, wherein the green tea flavonoid and chlorophyll are used in combination.
請求項１〜３のいずれかに記載の消臭スプレー。4. The deodorant spray according to claim 1, wherein the deodorant is jetted.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11167462A JP2000354623A (en) | 1999-06-14 | 1999-06-14 | Deodorant and deodorizing spray |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11167462A JP2000354623A (en) | 1999-06-14 | 1999-06-14 | Deodorant and deodorizing spray |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000354623A true JP2000354623A (en) | 2000-12-26 |
Family
ID=15850137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11167462A Pending JP2000354623A (en) | 1999-06-14 | 1999-06-14 | Deodorant and deodorizing spray |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2000354623A (en) |
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8114385B2 (en) | 2003-08-04 | 2012-02-14 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8119106B2 (en) | 2003-04-28 | 2012-02-21 | Foamix Ltd | Foamable iodine compositions |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US8709385B2 (en) | 2008-01-14 | 2014-04-29 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
-
1999
- 1999-06-14 JP JP11167462A patent/JP2000354623A/en active Pending
Cited By (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
| US8119150B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Non-flammable insecticide composition and uses thereof |
| US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
| US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
| US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
| US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US8840869B2 (en) | 2002-10-25 | 2014-09-23 | Foamix Ltd. | Body cavity foams |
| US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
| US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
| US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US8119109B2 (en) | 2002-10-25 | 2012-02-21 | Foamix Ltd. | Foamable compositions, kits and methods for hyperhidrosis |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
| US8119106B2 (en) | 2003-04-28 | 2012-02-21 | Foamix Ltd | Foamable iodine compositions |
| US8703105B2 (en) | 2003-08-04 | 2014-04-22 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
| US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8114385B2 (en) | 2003-08-04 | 2012-02-14 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
| US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
| US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
| US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
| US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
| US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
| US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US8709385B2 (en) | 2008-01-14 | 2014-04-29 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
| US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
| US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
| US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
| US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
| US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
| US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
| US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
| US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
| US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
| US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000354623A (en) | Deodorant and deodorizing spray | |
| JP6139660B2 (en) | Odor reducing composition | |
| JP5475892B2 (en) | Malodor control composition having acid catalyst and method thereof | |
| JP5620514B2 (en) | Malodor control composition having a mixture of volatile aldehydes and method thereof | |
| JP3947149B2 (en) | Deodorant composition | |
| ES2706288T3 (en) | Compositions that neutralize odors and procedure for their use | |
| BR0116345B1 (en) | Smelly counteracting composition, process for dispersing said composition, process for imparting a MOC effect to a substrate and fragrance composition | |
| JP5711385B2 (en) | Non-fragrance and low-fragrance malodor control composition and method | |
| CN111432851B (en) | Use of volatile components to limit or eliminate perception of malodor | |
| US9642927B2 (en) | Unscented and low scented malodor control compositions and methods thereof | |
| KR20170066420A (en) | Malodor reducing compositions | |
| US20160129145A1 (en) | Method of neutralizing malodors | |
| KR101781657B1 (en) | Deodorant composition comprising essential oil from plant | |
| CN106999619A (en) | The macrocyclic ketone of composition is offset as stench | |
| JP4469097B2 (en) | Deodorant for toilet | |
| JP2001335501A (en) | Drinking water for deodorant | |
| EP1393752A1 (en) | Malodor suppression by fragrance composition | |
| JP2003055896A (en) | Deodorizing paper |